combining egfr and vegf inhibitors for nsclc
Published 3 years ago • 303 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
1:41
efficacy of dual egfr and met inhibition in nsclc post egfr tki failure
-
0:57
combined inhibition of parp and vegf in gastric cancer
-
5:06
combination strategies with vegf-targeted therapy in nsclc
-
1:31
combining immunotherapy with vegf inhibitors to treat kidney cancer
-
4:40
egfr-vegf inhibition for first-line egfr mnsclc treatment
-
2:36
atezolizumab with erlotinib in combination treatment for egfr mutant nsclc
-
1:18
examining the combination of egfr inhibition plus chemotherapy in lung cancer
-
1:09
current and novel treatment approaches for first-line egfr-m nsclc
-
3:51
combining braf, mek and egfr inhibition in mcrc
-
58:47
15 years of advances in egfr mutant lung cancer
-
4:24
vegf inhibition in nsclc
-
0:55
flowers: osimertinib and savolitinib in met aberrant, egfrm nsclc
-
1:52
patritumab deruxtecan in patients with egfr-mutant nsclc
-
2:38
combining bevacizumab with egfr tkis in lung cancer
-
1:51
evaluating first-line therapies for egfr-mutated nsclc in 2024
-
6:23
frontline chemo and tki combination in egfr nsclc
-
7:00
researcher comment: dual egfr inhibition for egfr-mutated nsclc | julia rotow
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
1:36
comment: front-line osimertinib significantly lengthens overall survival in egfr-mutation positi...